Thông tin tài liệu
Thông tin siêu dữ liệu biểu ghi
| Trường DC | Giá trị | Ngôn ngữ |
|---|---|---|
| dc.contributor.author | Pham Thi Van Anh, Nguyen Phuong Thanh | - |
| dc.contributor.author | Dau Thuy Duong | - |
| dc.date.accessioned | 2023-02-08T08:57:48Z | - |
| dc.date.available | 2023-02-08T08:57:48Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.uri | http://thuvienso.thanglong.edu.vn//handle/TLU/5629 | - |
| dc.description | Số 148 E9 (12): Tr. 68-77 | vi |
| dc.description.abstract | A double-blind, randomized, phase II clinical trial was conducted within a 14-week follow-up including 2 weeks of the non-drug run-in period, 8 weeks of medication, and 4 weeks of follow-up after discontinuation. The objective of the study was to evaluate the efficacy and safety of Trang Phuc Linh Plus in irritable diarrhea syndrome patients. Group I took Trang Phuc Linh Plus 3 tablets/time x 2 times/day for 8 weeks; Group II took placebo 3 tablets/ time x 2 times/day for 8 weeks. Patients will be re-examined, tested, and evaluated over the phone for symptom recurrence and adverse events (AEs). This study showed that the Trang Phuc Linh Plus tablets tended to improve symptoms in patients suffering from irritable bowel syndrome with diarrhea, suggesting its safety and tolerability | vi |
| dc.language.iso | en | vi |
| dc.publisher | Journal of Medical Research | vi |
| dc.subject | irritable bowel syndrome | vi |
| dc.subject | Trang Phuc Linh Plus | vi |
| dc.title | Efficacy and safety of Trang phuc linh plus tablets in patients with irritable bowel syndrome-diarrhea | vi |
| dc.type | Article | vi |
| Bộ sưu tập | Lĩnh vực Khoa học sức khỏe | |
Danh sách tệp tin đính kèm:
